Physiological sodium and chloride ion channels and transport processes (N/A)

Physiological sodium and chloride ion channels and transport processes represent a broad functional category of membrane proteins responsible for maintaining ionic gradients and osmotic balance across biological membranes. This group includes voltage-gated sodium channels (e.g., SCN5A) critical for cardiac and neuronal action potentials, and chloride channels (e.g., CLCN1, CFTR) that regulate cell volume and epithelial fluid transport (UniProt, 2024). It also encompasses secondary active transporters such as the sodium-potassium-chloride cotransporters (NKCC1/2) and the sodium-chloride symporter (NCC), which are primary targets for antihypertensive therapy in the kidney (StatPearls, 2023). Mutations or dysregulation in these proteins are central to the pathogenesis of diseases like cystic fibrosis, Liddle syndrome, and various forms of epilepsy and arrhythmia (PubMed, 2022). Therapeutic agents interacting with these processes include loop diuretics, thiazides, and sodium channel blockers, which modulate ion flux to treat fluid overload, hypertension, and excitability disorders (PubChem, 2024).

Other names

Sodium and chloride transport systemsNaCl transportIon transport processesTransmembrane sodium and chloride movement

Drugs targeting these processes typically act by inhibiting ion flux through competitive binding to solute carrier proteins (e.g., NCC, NKCC2) or by physically blocking the pore or modulating the gating kinetics of ion channels (e.g., Nav, CFTR) (StatPearls, 2023; PubChem, 2024).